Recap: Monopar Therapeutics Q3 Earnings

Monopar Therapeutics (NASDAQ:MNPR) reported its Q3 earnings results on Thursday, November 9, 2023 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Monopar Therapeutics beat estimated earnings by 17.65%, reporting an EPS of $-0.14 versus an estimate of $-0.17.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 5.21% drop in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Monopar Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.